{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:36:23Z","timestamp":1788611783921,"version":"build-2803163510"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00018-020-03580-1","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T01:04:01Z","timestamp":1593824641000},"page":"1501-1522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies"],"prefix":"10.1007","volume":"78","author":[{"given":"Ivan","family":"Mercurio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Tragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Busto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7273-4263","authenticated-orcid":false,"given":"Anna","family":"De Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-548X","authenticated-orcid":false,"given":"Ciro Leonardo","family":"Pierri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,4]]},"reference":[{"key":"3580_CR1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.AC120.013056","author":"CJ Gordon","year":"2020","unstructured":"Gordon CJ, Tchesnokov EP, Feng JY et al (2020) The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.AC120.013056","journal-title":"J Biol Chem"},{"key":"3580_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117592","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA (2020) Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2020.117592","journal-title":"Life Sci"},{"issue":"3","key":"3580_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L et al (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269\u2013271","journal-title":"Cell Res"},{"key":"3580_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.02.008","author":"C Wu","year":"2020","unstructured":"Wu C, Liu Y, Yang Y et al (2020) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008","journal-title":"Acta Pharm Sin B"},{"key":"3580_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10280-3","author":"RN Kirchdoerfer","year":"2019","unstructured":"Kirchdoerfer RN, Ward AB (2019) Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-10280-3","journal-title":"Nat Commun"},{"key":"3580_CR6","doi-asserted-by":"publisher","first-page":"107512","DOI":"10.1016\/j.pharmthera.2020.107512","volume":"209","author":"K Shiraki","year":"2020","unstructured":"Shiraki K, Daikoku T (2020) Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol Ther 209:107512. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107512","journal-title":"Pharmacol Ther"},{"key":"3580_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/v11100964","author":"PI Andersen","year":"2019","unstructured":"Andersen PI, Krpina K, Ianevski A et al (2019) Novel antiviral activities of obatoclax, emetine, niclosamide, brequinar, and homoharringtonine. Viruses. https:\/\/doi.org\/10.3390\/v11100964","journal-title":"Viruses"},{"key":"3580_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"3580_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/minf.202000028","author":"A-T Ton","year":"2020","unstructured":"Ton A-T, Gentile F, Hsing M et al (2020) Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds. Mol Inform. https:\/\/doi.org\/10.1002\/minf.202000028","journal-title":"Mol Inform"},{"key":"3580_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb3405","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lin D, Sun X et al (2020) Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science. https:\/\/doi.org\/10.1126\/science.abb3405","journal-title":"Science"},{"issue":"7811","key":"3580_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y et al (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582(7811):289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y","journal-title":"Nature."},{"key":"3580_CR12","doi-asserted-by":"publisher","unstructured":"Palese LL (2020) The structural landscape of SARS-CoV-2 main protease: hints for inhibitor search 1\u201313. https:\/\/doi.org\/10.26434\/chemrxiv.12209744.v1","DOI":"10.26434\/chemrxiv.12209744.v1"},{"key":"3580_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104742","author":"B Coutard","year":"2020","unstructured":"Coutard B, Valle C, de Lamballerie X et al (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir Res. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104742","journal-title":"Antivir Res"},{"key":"3580_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14817","author":"N Tang","year":"2020","unstructured":"Tang N, Bai H, Chen X et al (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14817","journal-title":"J Thromb Haemost"},{"key":"3580_CR15","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0188","author":"H Han","year":"2020","unstructured":"Han H, Yang L, Liu R et al (2020) Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. https:\/\/doi.org\/10.1515\/cclm-2020-0188","journal-title":"Clin Chem Lab Med"},{"key":"3580_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14768","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14768","journal-title":"J Thromb Haemost"},{"key":"3580_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02105-8","author":"S Yin","year":"2020","unstructured":"Yin S, Huang M, Li D, Tang N (2020) Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. https:\/\/doi.org\/10.1007\/s11239-020-02105-8","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"3580_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20(6):363\u2013374. https:\/\/doi.org\/10.1038\/s41577-020-0311-8","journal-title":"Nat Rev Immunol"},{"key":"3580_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"6736","author":"P Mehta","year":"2020","unstructured":"Mehta P, Mcauley DF, Brown M et al (2020) Correspondence COVID-19: consider cytokine storm syndromes and. Lancet 6736:19\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"3580_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046941","author":"KJ Clerkin","year":"2020","unstructured":"Clerkin KJ, Fried JA, Raikhelkar J et al (2020) Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046941","journal-title":"Circulation"},{"key":"3580_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijcard.2019.05.028","volume":"292","author":"V Quagliariello","year":"2019","unstructured":"Quagliariello V, Passariello M, Coppola C et al (2019) Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab. Int J Cardiol 292:171\u2013179. https:\/\/doi.org\/10.1016\/j.ijcard.2019.05.028","journal-title":"Int J Cardiol"},{"issue":"4","key":"3580_CR22","doi-asserted-by":"publisher","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","volume":"55","author":"P Colson","year":"2020","unstructured":"Colson P, Rolain JM, Lagier JC et al (2020) Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents 55(4):105932","journal-title":"Int J Antimicrob Agents"},{"key":"3580_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.03.040","author":"M Sodhi","year":"2020","unstructured":"Sodhi M, Etminan M (2020) Safety of ibuprofen in patients with COVID-19; causal or confounded? Chest. https:\/\/doi.org\/10.1016\/j.chest.2020.03.040","journal-title":"Chest"},{"key":"3580_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS et al (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. https:\/\/doi.org\/10.1126\/science.abb2507","journal-title":"Science"},{"key":"3580_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.058","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park Y-J, Tortorici MA et al (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.02.058","journal-title":"Cell"},{"key":"3580_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2762","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y et al (2020) Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science. https:\/\/doi.org\/10.1126\/science.abb2762","journal-title":"Science"},{"key":"3580_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.045","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhang Y, Wu L et al (2020) Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.03.045","journal-title":"Cell"},{"key":"3580_CR28","doi-asserted-by":"publisher","unstructured":"Lei C, Fu W, Qian K et al (2020) Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig. bioRxiv:2020.02.01.929976. https:\/\/doi.org\/10.1101\/2020.02.01.929976","DOI":"10.1101\/2020.02.01.929976"},{"key":"3580_CR29","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1038\/s41467-020-16256-y","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang C, Li W, Drabek D et al (2020) A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun 11:2511. https:\/\/doi.org\/10.1038\/s41467-020-16256-y","journal-title":"Nat Commun"},{"key":"3580_CR30","doi-asserted-by":"publisher","unstructured":"Park T, Lee S-Y, Kim S et al (2020) Spike protein binding prediction with neutralizing antibodies of SARS-CoV-2. bioRxiv:2020.02.22.951178. https:\/\/doi.org\/10.1101\/2020.02.22.951178","DOI":"10.1101\/2020.02.22.951178"},{"key":"3580_CR31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307140101","author":"J Sui","year":"2004","unstructured":"Sui J, Li W, Murakami A et al (2004) Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.0307140101","journal-title":"Proc Natl Acad Sci USA"},{"key":"3580_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc1932","author":"Q Gao","year":"2020","unstructured":"Gao Q, Bao L, Mao H et al (2020) Development of an inactivated vaccine candidate for SARS-CoV-2. Science (80-). https:\/\/doi.org\/10.1126\/science.abc1932","journal-title":"Science (80-)"},{"key":"3580_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9050324","author":"T Koyama","year":"2020","unstructured":"Koyama T, Weeraratne D, Snowdon JL, Parida L (2020) Emergence of drift variants that may affect covid-19 vaccine development and antibody treatment. Pathogens. https:\/\/doi.org\/10.3390\/pathogens9050324","journal-title":"Pathogens"},{"issue":"1","key":"3580_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","volume":"9","author":"X Tian","year":"2020","unstructured":"Tian X, Li C, Huang A et al (2020) Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect 9(1):382\u2013385. https:\/\/doi.org\/10.1080\/22221751.2020.1729069","journal-title":"Emerg Microbes Infect"},{"key":"3580_CR35","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/bioinformatics\/btp302","volume":"25","author":"A Lobley","year":"2009","unstructured":"Lobley A, Sadowski MI, Jones DT (2009) pGenTHREADER and pDomTHREADER: new methods for improved protein fold recognition and superfamily discrimination. Bioinformatics 25:1761\u20131767","journal-title":"Bioinformatics"},{"key":"3580_CR36","doi-asserted-by":"publisher","first-page":"5.8.1","DOI":"10.1002\/0471250953.bi0508s52","volume":"52","author":"J Yang","year":"2015","unstructured":"Yang J, Zhang Y (2015) Protein structure and function prediction using I-TASSER. Curr Protoc Bioinform 52:5.8.1\u20135.8.15. https:\/\/doi.org\/10.1002\/0471250953.bi0508s52","journal-title":"Curr Protoc Bioinform"},{"key":"3580_CR37","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3390\/jcm8122117","volume":"8","author":"L Trisolini","year":"2019","unstructured":"Trisolini L, Gambacorta N, Gorgoglione R et al (2019) FAD\/NADH dependent oxidoreductases: from different amino acid sequences to similar protein shapes for playing an ancient function. J Clin Med 8:2117. https:\/\/doi.org\/10.3390\/jcm8122117","journal-title":"J Clin Med"},{"issue":"9","key":"3580_CR38","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.bbapap.2010.04.008","volume":"1804","author":"CL Pierri","year":"2010","unstructured":"Pierri CL, Parisi G, Porcelli V (2010) Computational approaches for protein function prediction: a combined strategy from multiple sequence alignment to molecular docking-based virtual screening. Biochim Biophys Acta 1804(9):1695\u20131712. https:\/\/doi.org\/10.1016\/j.bbapap.2010.04.008","journal-title":"Biochim Biophys Acta"},{"key":"3580_CR39","first-page":"215","volume":"88","author":"B Persson","year":"2000","unstructured":"Persson B (2000) Bioinformatics in protein analysis. EXS 88:215\u2013231","journal-title":"EXS"},{"key":"3580_CR40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","volume":"25","author":"AM Waterhouse","year":"2009","unstructured":"Waterhouse AM, Procter JB, Martin DM et al (2009) Jalview Version 2\u2014a multiple sequence alignment editor and analysis workbench. Bioinformatics 25:1189\u20131191","journal-title":"Bioinformatics"},{"key":"3580_CR41","doi-asserted-by":"publisher","first-page":"346","DOI":"10.6026\/97320630002346","volume":"2","author":"R Ordog","year":"2008","unstructured":"Ordog R (2008) PyDeT, a PyMOL plug-in for visualizing geometric concepts around proteins. Bioinformation 2:346\u2013347","journal-title":"Bioinformation"},{"key":"3580_CR42","doi-asserted-by":"publisher","first-page":"e00197","DOI":"10.1002\/prp2.197","volume":"4","author":"CL Pierri","year":"2016","unstructured":"Pierri CL, Bossis F, Punzi G et al (2016) Molecular modeling of antibodies for the treatment of TNF\u03b1-related immunological diseases. Pharmacol Res Perspect 4:e00197. https:\/\/doi.org\/10.1002\/prp2.197","journal-title":"Pharmacol Res Perspect"},{"issue":"77 Suppl 9","key":"3580_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/prot.22570","volume":"77","author":"E Krieger","year":"2009","unstructured":"Krieger E, Joo K, Lee J et al (2009) Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins 77 Suppl 9(Suppl 9):114\u2013122. https:\/\/doi.org\/10.1002\/prot.22570","journal-title":"Proteins"},{"key":"3580_CR44","first-page":"97","volume":"143","author":"R Sanchez","year":"2000","unstructured":"Sanchez R, Sali A, S\u00e1nchez R, Sali A (2000) Comparative protein structure modeling. Introduction and practical examples with modeller. Methods Mol Biol 143:97\u2013129","journal-title":"Methods Mol Biol"},{"key":"3580_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1708727114","author":"AC Walls","year":"2017","unstructured":"Walls AC, Tortorici MA, Snijder J et al (2017) Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.1708727114","journal-title":"Proc Natl Acad Sci USA"},{"key":"3580_CR46","doi-asserted-by":"publisher","DOI":"10.1107\/S2059798318008318","author":"L Yan","year":"2018","unstructured":"Yan L, Meng B, Xiang J et al (2018) Crystal structure of the post-fusion core of the Human coronavirus 229E spike protein at 1.86\u00a0\u00c5 resolution. Acta Crystallogr Sect D Struct Biol. https:\/\/doi.org\/10.1107\/S2059798318008318","journal-title":"Acta Crystallogr Sect D Struct Biol"},{"key":"3580_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.02.022","author":"S Duquerroy","year":"2005","unstructured":"Duquerroy S, Vigouroux A, Rottier PJM et al (2005) Central ions and lateral asparagine\/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein. Virology. https:\/\/doi.org\/10.1016\/j.virol.2005.02.022","journal-title":"Virology"},{"key":"3580_CR48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403760200","author":"Y Xu","year":"2004","unstructured":"Xu Y, Liu Y, Lou Z et al (2004) Structural basis for coronavirus-mediated membrane fusion: crystal structure of mouse hepatitis virus spike protein fusion core. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M403760200","journal-title":"J Biol Chem"},{"key":"3580_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007236","author":"W Song","year":"2018","unstructured":"Song W, Gui M, Wang X, Xiang Y (2018) Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1007236","journal-title":"PLoS Pathog"},{"key":"3580_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34171-7","author":"RN Kirchdoerfer","year":"2018","unstructured":"Kirchdoerfer RN, Wang N, Pallesen J et al (2018) Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-018-34171-7","journal-title":"Sci Rep"},{"key":"3580_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/science.1116480","author":"F Li","year":"2005","unstructured":"Li F, Li W, Farzan M, Harrison SC (2005) Structural biology: structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science (80-). https:\/\/doi.org\/10.1126\/science.1116480","journal-title":"Science (80-)"},{"key":"3580_CR52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M600697200","author":"P Prabakaran","year":"2006","unstructured":"Prabakaran P, Gan J, Feng Y et al (2006) Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M600697200","journal-title":"J Biol Chem"},{"key":"3580_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.12.028","author":"AC Walls","year":"2019","unstructured":"Walls AC, Xiong X, Park YJ et al (2019) Unexpected receptor functional mimicry elucidates activation of coronavirus fusion. Cell. https:\/\/doi.org\/10.1016\/j.cell.2018.12.028","journal-title":"Cell"},{"issue":"1","key":"3580_CR54","doi-asserted-by":"publisher","first-page":"2.8.1\u20132.8.17","DOI":"10.1002\/0471140864.ps0208s23","volume":"23","author":"N Guex","year":"2001","unstructured":"Guex N, Schwede T, Peitsch MC (2001) Protein tertiary structure modeling. Curr Protoc Protein Sci 23(1):2.8.1\u20132.8.17. https:\/\/doi.org\/10.1002\/0471140864.ps0208s23","journal-title":"Curr Protoc Protein Sci"},{"key":"3580_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2014.17","volume-title":"The PyMOL molecular graphics system, version 1.1","author":"WL DeLano","year":"2002","unstructured":"DeLano WL (2002) The PyMOL molecular graphics system, version 1.1. Schr\u00f6dinger LLC, New York. https:\/\/doi.org\/10.1038\/hr.2014.17"},{"key":"3580_CR56","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1021\/bi962514+","volume":"36","author":"LJ Harris","year":"1997","unstructured":"Harris LJ, Larson SB, Hasel KW, McPherson A (1997) Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36:1581\u20131597. https:\/\/doi.org\/10.1021\/bi962514+","journal-title":"Biochemistry"},{"key":"3580_CR57","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.7b00125","author":"RF Alford","year":"2017","unstructured":"Alford RF, Leaver-Fay A, Jeliazkov JR et al (2017) The Rosetta all-atom energy function for macromolecular modeling and design. J Chem Theory Comput. https:\/\/doi.org\/10.1021\/acs.jctc.7b00125","journal-title":"J Chem Theory Comput"},{"key":"3580_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059004","author":"LG Niv\u00f3n","year":"2013","unstructured":"Niv\u00f3n LG, Moretti R, Baker D (2013) A Pareto-optimal refinement method for protein design scaffolds. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0059004","journal-title":"PLoS ONE"},{"key":"3580_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/pro.2389","author":"P Conway","year":"2014","unstructured":"Conway P, Tyka MD, DiMaio F et al (2014) Relaxation of backbone bond geometry improves protein energy landscape modeling. Protein Sci. https:\/\/doi.org\/10.1002\/pro.2389","journal-title":"Protein Sci"},{"key":"3580_CR60","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1093\/bioinformatics\/btr254","volume":"27","author":"J Van Durme","year":"2011","unstructured":"Van Durme J, Delgado J, Stricher F et al (2011) A graphical interface for the FoldX forcefield. Bioinformatics 27:1711\u20131712. https:\/\/doi.org\/10.1093\/bioinformatics\/btr254","journal-title":"Bioinformatics"},{"key":"3580_CR61","doi-asserted-by":"publisher","first-page":"W382","DOI":"10.1093\/nar\/gki387","volume":"33","author":"J Schymkowitz","year":"2005","unstructured":"Schymkowitz J, Borg J, Stricher F et al (2005) The FoldX web server: an online force field. Nucleic Acids Res 33:W382\u2013W388. https:\/\/doi.org\/10.1093\/nar\/gki387","journal-title":"Nucleic Acids Res"},{"key":"3580_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/pro.2187","author":"P Benjamin Stranges","year":"2013","unstructured":"Benjamin Stranges P, Kuhlman B (2013) A comparison of successful and failed protein interface designs highlights the challenges of designing buried hydrogen bonds. Protein Sci. https:\/\/doi.org\/10.1002\/pro.2187","journal-title":"Protein Sci"},{"key":"3580_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/prot.25353","author":"A Bazzoli","year":"2017","unstructured":"Bazzoli A, Vance DJ, Rudolph MJ et al (2017) Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodies. Proteins Struct Funct Bioinform. https:\/\/doi.org\/10.1002\/prot.25353","journal-title":"Proteins Struct Funct Bioinform"},{"key":"3580_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020872","author":"SM Lewis","year":"2011","unstructured":"Lewis SM, Kuhlman BA (2011) Anchored design of protein\u2013protein interfaces. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0020872","journal-title":"PLoS ONE"},{"key":"3580_CR65","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","author":"MR Deshotels","year":"2014","unstructured":"Deshotels MR, Xia H, Sriramula S et al (2014) Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an Angiotensin II type I receptor-dependent mechanism. Hypertension. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03743","journal-title":"Hypertension"},{"key":"3580_CR66","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00127-20","author":"Y Wan","year":"2020","unstructured":"Wan Y, Shang J, Graham R et al (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. https:\/\/doi.org\/10.1128\/jvi.00127-20","journal-title":"J Virol"},{"key":"3580_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2179-y","author":"J Shang","year":"2020","unstructured":"Shang J, Ye G, Shi K et al (2020) Structural basis of receptor recognition by SARS-CoV-2. Nature. https:\/\/doi.org\/10.1038\/s41586-020-2179-y","journal-title":"Nature"},{"key":"3580_CR68","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1996.0617","author":"ACR Martin","year":"1996","unstructured":"Martin ACR, Thornton JM (1996) Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies. J Mol Biol. https:\/\/doi.org\/10.1006\/jmbi.1996.0617","journal-title":"J Mol Biol"},{"key":"3580_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s40475-020-00201-6","author":"WH Chen","year":"2020","unstructured":"Chen WH, Strych U, Hotez PJ, Bottazzi ME (2020) The SARS-CoV-2 vaccine pipeline: an overview. Curr Trop Med Rep. https:\/\/doi.org\/10.1007\/s40475-020-00201-6","journal-title":"Curr Trop Med Rep"},{"key":"3580_CR70","doi-asserted-by":"publisher","first-page":"102743","DOI":"10.1016\/j.ebiom.2020.102743","volume":"55","author":"E Kim","year":"2020","unstructured":"Kim E, Erdos G, Huang S et al (2020) Microneedle array delivered recombinant coronavirus vaccines: immunogenicity and rapid translational development. EBioMedicine 55:102743. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102743","journal-title":"EBioMedicine"},{"key":"3580_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/v12030254","author":"SF Ahmed","year":"2020","unstructured":"Ahmed SF, Quadeer AA, McKay MR (2020) Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses. https:\/\/doi.org\/10.3390\/v12030254","journal-title":"Viruses"},{"issue":"4","key":"3580_CR72","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","volume":"26","author":"I Thevarajan","year":"2020","unstructured":"Thevarajan I, Nguyen THO, Koutsakos M et al (2020) Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med 26(4):453\u2013455. https:\/\/doi.org\/10.1038\/s41591-020-0819-2","journal-title":"Nat Med"},{"issue":"21","key":"3580_CR73","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1056\/NEJMp2005630","volume":"382","author":"N Lurie","year":"2020","unstructured":"Lurie N, Saville M, Hatchett R, Halton J (2020) Developing Covid-19 vaccines at pandemic speed. N Engl J Med 382(21):1969\u20131973. https:\/\/doi.org\/10.1056\/NEJMp2005630","journal-title":"N Engl J Med"},{"key":"3580_CR74","doi-asserted-by":"publisher","unstructured":"Joyce MG, Sankhala RS, Chen W-H, Choe M, Bai H, Hajduczki A, Yan L, Sterling SL, Peterson CE, Green EC, Smith C, de Val N, Amare M, Scott P, Laing ED, Christopher KM (2020) A cryptic site of vulnerability on the receptor binding domain of the SARS-CoV-2 spike glycoprotein. bioRxiv. https:\/\/doi.org\/10.1101\/2020.03.15.992883v1","DOI":"10.1101\/2020.03.15.992883v1"},{"key":"3580_CR75","doi-asserted-by":"publisher","first-page":"eabb7269","DOI":"10.1126\/science.abb7269","volume":"7269","author":"M Yuan","year":"2020","unstructured":"Yuan M, Wu NC, Zhu X et al (2020) A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV. Science (80-) 7269:eabb7269. https:\/\/doi.org\/10.1126\/science.abb7269","journal-title":"Science (80-)"},{"key":"3580_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25736","author":"M Bhattacharya","year":"2020","unstructured":"Bhattacharya M, Sharma AR, Patra P et al (2020) Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.25736","journal-title":"J Med Virol"},{"key":"3580_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0913-5","author":"F Amanat","year":"2020","unstructured":"Amanat F, Stadlbauer D, Strohmeier S et al (2020) A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. https:\/\/doi.org\/10.1038\/s41591-020-0913-5","journal-title":"Nat Med"},{"issue":"4","key":"3580_CR78","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1473-3099(20)30141-9","volume":"20","author":"L Chen","year":"2020","unstructured":"Chen L, Xiong J, Bao L, Shi Y (2020) Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 20(4):398\u2013400. https:\/\/doi.org\/10.1016\/S1473-3099(20)30141-9","journal-title":"Lancet Infect Dis"},{"key":"3580_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104787","author":"L Caly","year":"2020","unstructured":"Caly L, Druce JD, Catton MG et al (2020) The FDA-approved DRUG Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir Res. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104787","journal-title":"Antivir Res"},{"key":"3580_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0153-3","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Hou Y, Shen J et al (2020) Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discov. https:\/\/doi.org\/10.1038\/s41421-020-0153-3","journal-title":"Cell Discov"},{"key":"3580_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2286-9","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Jang GM, Bouhaddou M et al (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. https:\/\/doi.org\/10.1038\/s41586-020-2286-9","journal-title":"Nature"},{"key":"3580_CR82","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/cells9051267","volume":"9","author":"M Romano","year":"2020","unstructured":"Romano M, Ruggiero A, Squeglia F, Maga G, Berisio R (2020) A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells 9:1267","journal-title":"Cells"},{"issue":"3","key":"3580_CR83","doi-asserted-by":"publisher","first-page":"e1004733","DOI":"10.1371\/journal.ppat.1004733","volume":"11","author":"L van der Linden","year":"2015","unstructured":"van der Linden L, Vives-Adri\u00e1n L, Selisko B et al (2015) The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family. PLoS Pathog 11(3):e1004733. https:\/\/doi.org\/10.1371\/journal.ppat.1004733","journal-title":"PLoS Pathog"},{"issue":"5","key":"3580_CR84","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2174\/138920311796391052","volume":"12","author":"A Consiglio","year":"2011","unstructured":"Consiglio A, Grillo G, Licciulli F et al (2011) PlantPIs\u2013an interactive web resource on plant protease inhibitors. Curr Protein Pept Sci 12(5):448\u2013454. https:\/\/doi.org\/10.2174\/138920311796391052","journal-title":"Curr Protein Pept Sci"},{"issue":"3","key":"3580_CR85","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jcv.2005.03.005","volume":"34","author":"A Savarino","year":"2005","unstructured":"Savarino A (2005) Expanding the frontiers of existing antiviral drugs: possible effects of HIV-1 protease inhibitors against SARS and avian influenza. J Clin Virol 34(3):170\u2013178. https:\/\/doi.org\/10.1016\/j.jcv.2005.03.005","journal-title":"J Clin Virol"},{"key":"3580_CR86","doi-asserted-by":"publisher","unstructured":"Bendavid E, Mulaney B, Sood N et al (2020) COVID-19 antibody seroprevalence in Santa Clara County, California. medRxiv:2020.04.14.20062463. https:\/\/doi.org\/10.1101\/2020.04.14.20062463","DOI":"10.1101\/2020.04.14.20062463"},{"key":"3580_CR87","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8259","author":"N Sethuraman","year":"2020","unstructured":"Sethuraman N, Jeremiah SS, Ryo A (2020) Interpreting diagnostic tests for SARS-CoV-2. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.8259","journal-title":"JAMA."},{"key":"3580_CR88","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00941-20","author":"A Bryan","year":"2020","unstructured":"Bryan A, Pepper G, Wener MH et al (2020) Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.00941-20","journal-title":"J Clin Microbiol"},{"key":"3580_CR89","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05985-9","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y et al (2020) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-020-05985-9","journal-title":"Intensive Care Med"},{"key":"3580_CR90","doi-asserted-by":"publisher","DOI":"10.1042\/CS20200163","author":"D Batlle","year":"2020","unstructured":"Batlle D, Wysocki J, Satchell K (2020) Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci (Lond). https:\/\/doi.org\/10.1042\/CS20200163","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"3580_CR91","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","volume":"17","author":"YY Zheng","year":"2020","unstructured":"Zheng YY, Ma YT, Zhang JY, Xie X (2020) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17(5):259\u2013260. https:\/\/doi.org\/10.1038\/s41569-020-0360-5","journal-title":"Nat Rev Cardiol."},{"key":"3580_CR92","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa235","author":"GM Kuster","year":"2020","unstructured":"Kuster GM, Pfister O, Burkard T et al (2020) SARS-CoV2: should inhibitors of the renin\u2013angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa235","journal-title":"Eur Heart J"},{"key":"3580_CR93","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311191200","author":"P Towler","year":"2004","unstructured":"Towler P, Staker B, Prasad SG et al (2004) ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M311191200","journal-title":"J Biol Chem"},{"key":"3580_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/nature01370","author":"R Natesh","year":"2003","unstructured":"Natesh R, Schwager SLU, Sturrock ED, Acharya KR (2003) Crystal structure of the human angiotensin-converting enzyme\u2013lisinopril complex. Nature. https:\/\/doi.org\/10.1038\/nature01370","journal-title":"Nature"},{"key":"3580_CR95","doi-asserted-by":"publisher","DOI":"10.1021\/bi049480n","author":"R Natesh","year":"2004","unstructured":"Natesh R, Schwager SLU, Evans HR et al (2004) Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry. https:\/\/doi.org\/10.1021\/bi049480n","journal-title":"Biochemistry"},{"key":"3580_CR96","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.512335","author":"CJ Yates","year":"2014","unstructured":"Yates CJ, Masuyer G, Schwager SLU et al (2014) Molecular and thermodynamic mechanisms of the chloride-dependent human angiotensin-I-converting enzyme (ACE). J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M113.512335","journal-title":"J Biol Chem"},{"key":"3580_CR97","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.510461","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC et al (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.510461","journal-title":"Circulation"},{"key":"3580_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2020.04.008","author":"M Alifano","year":"2020","unstructured":"Alifano M, Alifano P, Forgez P, Iannelli A (2020) Renin-angiotensin system at the heart of COVID-19 pandemic. Biochimie. https:\/\/doi.org\/10.1016\/j.biochi.2020.04.008","journal-title":"Biochimie"},{"key":"3580_CR99","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.120.317134","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J et al (2020) Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. https:\/\/doi.org\/10.1161\/circresaha.120.317134","journal-title":"Circ Res"},{"key":"3580_CR100","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav4580","author":"S Xia","year":"2019","unstructured":"Xia S, Yan L, Xu W et al (2019) A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.aav4580","journal-title":"Sci Adv"},{"issue":"5","key":"3580_CR101","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.coi.2013.08.004","volume":"25","author":"GL Law","year":"2013","unstructured":"Law GL, Tisoncik-Go J, Korth MJ, Katze MG (2013) Drug repurposing: a better approach for infectious disease drug discovery? Curr Opin Immunol 25(5):588\u2013592. https:\/\/doi.org\/10.1016\/j.coi.2013.08.004","journal-title":"Curr Opin Immunol"},{"key":"3580_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05116-5","author":"F Cheng","year":"2018","unstructured":"Cheng F, Desai RJ, Handy DE et al (2018) Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-05116-5","journal-title":"Nat Commun"},{"key":"3580_CR103","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1126\/science.1061692","volume":"293","author":"EO Saphire","year":"2001","unstructured":"Saphire EO, Parren PWHI, Pantophlet R et al (2001) Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design. Science (80-) 293:1155\u20131159. https:\/\/doi.org\/10.1126\/science.1061692","journal-title":"Science (80-)"},{"key":"3580_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2004.03.007","author":"PB Furtado","year":"2004","unstructured":"Furtado PB, Whitty PW, Robertson A et al (2004) Solution structure determination of monomeric human IgA2 by X-ray and neutron scattering, analytical ultracentrifugation and constrained modelling: a comparison with monomeric human IgA1. J Mol Biol. https:\/\/doi.org\/10.1016\/j.jmb.2004.03.007","journal-title":"J Mol Biol"},{"key":"3580_CR105","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M807529200","author":"A Bonner","year":"2009","unstructured":"Bonner A, Almogren A, Furtado PB et al (2009) The nonplanar secretory IgA2 and near planar secretory IgA1 solution structures rationalize their different mucosal immune responses. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M807529200","journal-title":"J Biol Chem"},{"key":"3580_CR106","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz5807","author":"N Kumar","year":"2020","unstructured":"Kumar N, Arthur CP, Ciferri C, Matsumoto ML (2020) Structure of the secretory immunoglobulin A core. Science (80-). https:\/\/doi.org\/10.1126\/science.aaz5807","journal-title":"Science (80-)"},{"issue":"1","key":"3580_CR107","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3201\/eid0501.990107","volume":"5","author":"L Zeitlin","year":"1999","unstructured":"Zeitlin L, Cone RA, Whaley KJ (1999) Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases. Emerg Infect Dis 5(1):54\u201364. https:\/\/doi.org\/10.3201\/eid0501.990107","journal-title":"Emerg Infect Dis"},{"key":"3580_CR108","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101317","author":"A Cerutti","year":"2011","unstructured":"Cerutti A, Chen K, Chorny A (2011) Immunoglobulin responses at the mucosal interface. Annu Rev Immunol. https:\/\/doi.org\/10.1146\/annurev-immunol-031210-101317","journal-title":"Annu Rev Immunol"},{"key":"3580_CR109","doi-asserted-by":"publisher","unstructured":"Chiara M, Horner DS, Pesole G (2020) Comparative genomics suggests limited variability and similar evolutionary patterns between major clades of SARS-Cov-2. bioRxiv:2020.03.30.016790. https:\/\/doi.org\/10.1101\/2020.03.30.016790","DOI":"10.1101\/2020.03.30.016790"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03580-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-020-03580-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03580-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T19:42:46Z","timestamp":1625341366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-020-03580-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,4]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["3580"],"URL":"https:\/\/doi.org\/10.1007\/s00018-020-03580-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.17.046185","asserted-by":"object"}]},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,4]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}